20th Anniversary of RNA Interference in Mammalian Cells

January 25th, 2021|Categories: Perspectives on Current Science|

The groundbreaking discovery of RNA interference by Craig Mello and Andrew Fire was swiftly followed by the discovery of RNAi as a gene-silencing mechanism in mammalian cells. Since these breakthroughs, members of our community have devoted their lives to building on these exciting discoveries, [...]

Oligonucleotides and the OTS Community Provide Excellent Solutions to the COVID-19 Pandemic

January 12th, 2021|Categories: Perspectives on Current Science|

Oligonucleotide therapies are relatively new in the field of medicine, but they have allowed us to make astounding progress in the fight against COVID-19. Rather than simply repurposing existing drugs or spending years to develop new drugs and vaccines, oligo therapies are quickly providing [...]

Oligonucleotide Therapeutics: New Drugs That Could Stop COVID-19

May 6th, 2020|Categories: Perspectives on Current Science|

In response to the COVID-19 pandemic, scientists around the world have joined together in applying their skills and technologies to fight this global threat. Some of the most promising technologies to fight the coronavirus are based on a new type of drug called oligonucleotide [...]

Coronavirus Highlights Urgent Need for Science-Backed Research

March 20th, 2020|Categories: Covid-19, Perspectives on Current Science|

News Release from Mary Ann Liebert, Inc. publishers Coronavirus Highlights Urgent Need for Science-Backed Research As an academic publisher, we publish many important resources relevant to COVID-19 such as Health Security, Viral Immunology, Telemedicine and e-Health, and Vector Borne and Zoonotic Diseases. We are keeping [...]

Go to Top